📰 Meitheal Pharmaceuticals News
Meitheal Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Meitheal Pharmaceuticals. Real-time updates on events, politics, business and more.
September 29, 2023
Insulin Biosimilars: Meitheal Pharmaceuticals, Inc. has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceuticals Co., Ltd. to commercialize Tonghua...
September 25, 2023
Prestige Biologics, a contract development and manufacturing organization (CDMO), announced it has signed a non-binding MOU with Aurigene…
August 28, 2023
Direct Relief Delivers $1 Billion in Donated Medicine and Medical Supplies ...
July 24, 2023
FMI expects The worldwide Antibiotics Active Pharmaceutical Ingredient (API) Market is supposed to accomplish a valuation of USD 8653.0 million in 2023 and is projected to arrive at USD 12002.3 million by 2033, following a CAGR of 3.3% during the estimated time frame.The World Health Organization (WHO) states that b...
December 23, 2022
Antibiotics Active Pharmaceutical Ingredient (API) Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2030
December 23, 2022
Antibiotics Active Pharmaceutical Ingredient (API) Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2030
December 23, 2022
Antibiotics Active Pharmaceutical Ingredient (API) Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2030
October 7, 2022
Since Sri Lanka announced in April that it would default on its foreign debt, its 22 million residents have lost access to most medicine and medical supplies, setting them on course for a humanitarian disaster. Unlike Russia’s invasion of Ukraine and the recent hurricane batterings of Puerto Rico and Florida, Sri Lanka’s crisis grew slowly […]